Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Sphingolipids for Cancer Therapy
Osmel Companioni, Cristina Mir, Yoelsis García-Mayea, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Functional roles of sphingolipids in immunity and their implication in disease
Mingyu Lee, Suh Yeon Lee, Yoe‐Sik Bae
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 6, pp. 1110-1130
Open Access | Times Cited: 65
Roles and therapeutic targeting of ceramide metabolism in cancer
Narendra Wajapeyee, Teresa Beamon, Romi Gupta
Molecular Metabolism (2024) Vol. 83, pp. 101936-101936
Open Access | Times Cited: 17
Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment
Alhaji H. Janneh, Besim Öğretmen
Cancers (2022) Vol. 14, Iss. 9, pp. 2183-2183
Open Access | Times Cited: 45
Targeting lipid metabolism in metastatic prostate cancer
Tahlia Scheinberg, Blossom Mak, Lisa M. Butler, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 22
Glucose Transporter 1-Mediated Transcytosis of Glucosamine-Labeled Liposomal Ceramide Targets Hypoxia Niches and Cancer Stem Cells to Enhance Therapeutic Efficacy
Lu-Yi Yu, Pei‐Wei Shueng, Hsin‐Cheng Chiu, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13158-13175
Closed Access | Times Cited: 17
Altered lipid metabolism as a predisposing factor for liver metastasis in MASLD
So Jung Kim, Jeongeun Hyun
Molecules and Cells (2024) Vol. 47, Iss. 2, pp. 100010-100010
Open Access | Times Cited: 6
The Role of Lipid Metabolism Disorders in the Development of Thyroid Cancer
Martyna Łukasiewicz, Agata Zwara, Jacek Kowalski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7129-7129
Open Access | Times Cited: 6
Fatty Acid 2-Hydroxylase and 2-Hydroxylated Sphingolipids: Metabolism and Function in Health and Diseases
Matthias Eckhardt
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4908-4908
Open Access | Times Cited: 14
The Critical Impact of Sphingolipid Metabolism in Breast Cancer Progression and Drug Response
Paola Antonia Corsetto, Stefania Zava, Angela Maria Rizzo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2107-2107
Open Access | Times Cited: 13
Neurotrophic Natural Products
Yoshiyasu Fukuyama, Miwa Kubo, Kenichi Harada
Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products (2024), pp. 1-473
Closed Access | Times Cited: 5
Thin Layer Chromatography Goes Ultrasmall to Assay Sphingosine Kinase Activation in Single Primary Leukemic Cells
Ming Yao, Yuli Wang, Lucas Cornwell, et al.
Analytical Chemistry (2025)
Closed Access
Drug Resistance: The Role of Sphingolipid Metabolism
Assem Zhakupova, Adelina Zeinolla, Kamilya Kokabi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3716-3716
Open Access
Recent Progress in the Development of Opaganib for the Treatment of Covid-19
Charles D. Smith, Lynn W. Maines, Staci N. Keller, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 2199-2211
Open Access | Times Cited: 18
Targeting Nutrient Dependency in Cancer Treatment
Kexin Fan, Zhan Liu, Min Gao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Emerging Roles of Ceramides in Breast Cancer Biology and Therapy
Purab Pal, G. Ekin Atilla‐Gokcumen, Jonna Frasor
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11178-11178
Open Access | Times Cited: 17
Investigating the Potential Use of Chemical Biopsy Devices to Characterize Brain Tumor Lipidomes
Joanna Bogusiewicz, Bogumiła Kupcewicz, Paulina Zofia Goryńska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3518-3518
Open Access | Times Cited: 16
Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia
Johnson Ung, Su‐Fern Tan, Todd E. Fox, et al.
Blood Reviews (2022) Vol. 55, pp. 100950-100950
Open Access | Times Cited: 16
C6 Ceramide Inhibits Canine Mammary Cancer Growth and Metastasis by Targeting EGR3 through JAK1/STAT3 Signaling
Jiayue Liu, Fangying Zhao, Yan Zhang, et al.
Animals (2024) Vol. 14, Iss. 3, pp. 422-422
Open Access | Times Cited: 3
De novo lipid synthesis and polarized prenylation drive cell invasion through basement membrane
Kieop Park, Aastha Garde, Siddharthan Balachandar Thendral, et al.
The Journal of Cell Biology (2024) Vol. 223, Iss. 10
Open Access | Times Cited: 3
Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival
Flora Nguyen Van Long, Délya Valcourt‐Gendron, Patrick Caron, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 12
Open Access | Times Cited: 7
Validated Lc-Ms/Ms Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application to Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide
Cristina Matteo, Isabella Orienti, Adriana Eramo, et al.
(2024)
Open Access | Times Cited: 2
Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide
Cristina Matteo, Isabella Orienti, Adriana Eramo, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 387-387
Open Access | Times Cited: 2
Sphingolipid Signaling and Complement Activation in Glioblastoma: A Promising Avenue for Therapeutic Intervention
Alhaji H. Janneh
BioChem (2024) Vol. 4, Iss. 2, pp. 126-143
Open Access | Times Cited: 2
Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets
Daniela N. Petrusca, Kelvin P. Lee, Deborah L. Galson
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Lipids as Targets for Renal Cell Carcinoma Therapy
Bisera Stepanovska Tanturovska, Roxana Manaila, Doriano Fabbro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3272-3272
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top